Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies

Pathobiology

Volumn 74, Issue 1, 2007, Pages 50-56

  Kato, M ^a   Claveria, F G ^a   Maki, Y ^a   Sanda, K ^a   Tanaka, T ^a   Omata, Y ^a   Nagasawa, H ^a   Suzuki, N ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

IgG antibodies; SAG1; Synthetic peptides; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE SAG1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLOOD SALVAGE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN STRUCTURE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TOXOPLASMA; TOXOPLASMOSIS;

MUS; TOXOPLASMA GONDII;

EID: 34248387206     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101051     Document Type: Article

References (39)

1. Black MW, Boothroyd JC: Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 2000;64:607-623.
2. Wichroski MJ, Melton JA, Donahue CG: Clostridium septicum alpha-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins. Infect Immun 2002;70:4353-4361.
3. Cesbron-Delauw MF, Guy B, Torpier G: Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci USA 1989;86:7537-7541.
4. Mineo JR, Kasper LH: Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30). Exp Parasitol 1994;79:11-20.
5. Lu F, Huang S, Hu MS, Kasper LH: Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect Immun 2005;73:5160-5165.
6. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-2095.
7. Asai T, Miura S, Sibley LD: Biochemical and molecular characterization of nucleoside triphosphate hydrolase isozymes from the parasitic protozoan Toxoplasma gondii. J Biol Chem 1995;270:11391-11397.
8. Kasper LH: Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii. Parasite Immunol 1987;9:433-445.
9. Kasper LH, Crabb JH, Pfefferkorn ER: Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. J Immunol 1983;130:2407-2412.
10. Lekutis C, Ferguson DJ, Boothroyd JC: Toxoplasma gondii: identification of a developmentally regulated family of genes related to SAG2. Exp Parasitol 2000;96:89-96.
11. Manger ID, Hehl AB, Boothroyd JC: The surface of Toxoplasma tachyzoites is dominated by a family of glycosylphosphatidylinositol-anchored antigens related to SAG1. Infect Immun 1998;66:2237-2244.
12. Kato M, Claveria FG, Maki Y: Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures. Pathobiology 2005;72:160-164.
13. Maki Y, Seng S, Kato M: Sequence analysis of three major antigens (p30, p23 and p22) of virulent and avirulent strains of Toxoplasma gondii. Infect Immun 1996;71:309-316.
14. Chou PY, Fasman GD: Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 1978;47:45-148.
15. Hopp TP, Woods KR: Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981;78:3824-3828.
16. Bourguin I, Moser M, Buzoni-Gatel D: Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect Immun 1998;66:4867-4874.
17. Khan IA, Ely KH, Kasper LH: A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. J Immunol 1991;147:3501-3506.
18. Seng S, Makala LH, Maki Y: Unresponsiveness to surface antigen 1 modifies cytokine profiles in acute Toxoplasma gondii infection. Pathobiology 2002;70:237-246.
19. Khan IA, Smith KA, Kasper LH: Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 1988;141:3600-3605.
20. Khan IA, Eckel ME, Pfefferkorn ER: Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J Infect Dis 1988;157:979-984.
21. Khan IA, Matsuura T, Kasper LH: Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994;62:1639-1642.
22. Khan IA, Ely KH, Kasper LH: Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. J Immunol 1994;152:1856-1860.
23. Parker SJ, Roberts CW, Alexander J: CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol 1991;84:207-212.
24. Seng S, Makala LH, Yokoyama M: SAG1 is a host-targeted antigen for protection against Toxoplasma gondii infection. Pathobiology 2004;71:144-151.
25. Vercammen M, Scorza T, Huygen K: DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000;68:38-45.
26. Pace CN, Scholtz JM: A helix propensity scale based on experimental studies of peptides and proteins. Biophys J 1998;75:422-427.
27. Nagel SD, Boothroyd JC: The major surface antigen, P30, of Toxoplasma gondii is anchored by a glycolipid. J Biol Chem 1989;264:5569-5574.
28. Kasper LH, Khan IA, Ely KH: Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J Immunol 1992;148:1493-1498.
29. Kodukula K, Gerber LD, Amthauer R: Biosynthesis of glycosyl phosphatidyl inositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment. J Cell Biol 1993;120:657-664.
30. Zinecker CF, Striepen B, Geyer H: Two glycoforms are present in the GPI-membrane anchor of the surface antigen 1 (P30) of Toxoplasma gondii. Mol Biochem Parasitol 2001;116:127-135.
31. Hansen DS, Siomos M, De Koning-Ward T, Buckingham L, Crabb BS, Schofield L : CD1r-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur J Immunol 2003;33:2588-2598.
32. Procopio DO, Almeida IC, Torrecilhas AC, Cardoso JE, Teyton L, Travassos LR, Bendelac A, Gazzinelli RT: Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J Immunol 2002;169:3926-3933.
33. Denkers EY, Gazzinelli RT: Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998;11:569-588.
34. Kasper LH, Khan IA : Role of p30 in host immunity and pathogenesis of T. gondii infection. Res Immunol 1993;144:45-48.
35. Nielsen HV, Lauemoller SL, Christiansen L: Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 1999;67:6358-6363.
36. Iwakura Y, Ishigame Y: The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218-1222.
37. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulate tissue inflammation by interleukin 17. Nat Immunol 2005;6:1133-1141.
38. Manetti R, Parronchi P, Giuduzu MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
39. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA: Role of interleukin-10 in regulation of T-cell-dependent and Tcell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun 1997;65:1675-1682.